{
  "schemaVersion": 1,
  "organisationId": "O-f4fbf60d2a2f4912ab798b2978fab52e",
  "slug": "sectra-b",
  "name": "SECTRA 'B'",
  "updatedAt": "2026-10-04T15:10:42.309894Z",
  "sections": [
    {
      "type": "OVERVIEW",
      "text": "Sectra AB is a Swedish technology company whose core businesses are medical imaging IT and cybersecurity. Its Imaging IT Solutions business provides systems for managing medical images and related information across specialties such as radiology, cardiology and pathology. Secure Communications supplies encryption and secure communications solutions, while Business Innovation includes activities in areas such as orthopaedics, genomics IT and medical education. [https://investor.sectra.com/this-is-sectra/our-business-operations/][https://investor.sectra.com/this-is-sectra/our-business-operations/imaging-it-solutions/][https://investor.sectra.com/this-is-sectra/our-business-operations/secure-communications/][https://investor.sectra.com/this-is-sectra/our-business-operations/business-innovation/]\n\nSectra describes its vision as contributing to a healthier and safer society. Founded in 1978 in Linköping, Sweden, the company has expanded internationally; in fiscal 2025/26, it reported net sales of SEK 3,541.7 million, more than 1,400 employees and customers in over 60 countries. [https://sectra.com/][https://investor.sectra.com/this-is-sectra/sectras-history/][https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf]\n[https://investor.sectra.com/this-is-sectra/our-business-operations/][https://investor.sectra.com/this-is-sectra/our-business-operations/imaging-it-solutions/][https://investor.sectra.com/this-is-sectra/our-business-operations/secure-communications/][https://investor.sectra.com/this-is-sectra/our-business-operations/business-innovation/][https://sectra.com/][https://investor.sectra.com/this-is-sectra/sectras-history/][https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf]",
      "updatedAt": "2026-10-04T15:10:42.309894Z"
    },
    {
      "type": "PRODUCTS",
      "text": "Sectra’s medical-imaging portfolio includes Sectra IDS7, an integrated diagnostic application, and Sectra VNA, a standards-based archive for centralizing medical images and other multimedia. Sectra One is its subscription offering, while Sectra One Cloud provides the imaging service as a managed cloud solution. The broader imaging portfolio includes digital pathology for diagnostic image review, analysis, reporting and collaboration; breast-imaging PACS/RIS; cardiology imaging; and orthopaedic planning software for procedures involving the hip, knee, shoulder, spine, trauma and revision surgery. [https://medical.sectra.com/product/sectra-ids7/][https://medical.sectra.com/product/sectra-vna/][https://medical.sectra.com/product/sectra-one-cloud/][https://medical.sectra.com/product/sectra-digital-pathology-solution/][https://medical.sectra.com/product/sectra-breast-imaging-pacs-ris/][https://medical.sectra.com/product/sectra-cardiology-solution/][https://medical.sectra.com/product/sectra-2d-planning-system/]\n\nSectra’s secure-communications products include Tiger/S, which provides encrypted speech, messaging and data transfer and is described as quantum-resilient and approved for classified use up to SECRET. Its cybersecurity services include Managed Detection and Response for operational technology and critical infrastructure, with continuous monitoring and incident-response support. The company also offers cloud implementation and operations, support, updates and monitoring for Sectra One Cloud. In April 2026, Sectra acquired Oxipit, whose autonomous chest X-ray AI is designed to identify likely normal examinations and filter them from radiologists’ worklists. [https://communications.sectra.com/product/mobile-communication-up-to-secret/][https://communications.sectra.com/product/sectra-managed-detection-and-response/][https://medical.sectra.com/product/sectra-one-cloud/][P124247344]\n\nSectra reports performance by operating area rather than providing a product-by-product revenue split; its published segment figures therefore do not establish individual products’ shares of company performance. [T14245175][T14245176][T14245177]\n[https://medical.sectra.com/product/sectra-ids7/][https://medical.sectra.com/product/sectra-vna/][https://medical.sectra.com/product/sectra-one-cloud/][https://medical.sectra.com/product/sectra-digital-pathology-solution/][https://medical.sectra.com/product/sectra-breast-imaging-pacs-ris/][https://medical.sectra.com/product/sectra-cardiology-solution/][https://medical.sectra.com/product/sectra-2d-planning-system/][https://communications.sectra.com/product/mobile-communication-up-to-secret/][https://communications.sectra.com/product/sectra-managed-detection-and-response/][P124247344][T14245175][T14245176][T14245177][https://medical.sectra.com/product/sectra-ids7/][https://medical.sectra.com/product/sectra-vna/][https://medical.sectra.com/product/sectra-one-cloud/][https://medical.sectra.com/product/sectra-digital-pathology-solution/][https://medical.sectra.com/product/sectra-breast-imaging-pacs-ris/][https://medical.sectra.com/product/sectra-cardiology-solution/][https://medical.sectra.com/product/sectra-2d-planning-system/][https://communications.sectra.com/product/mobile-communication-up-to-secret/][https://communications.sectra.com/product/sectra-managed-detection-and-response/]",
      "updatedAt": "2026-10-04T15:10:42.309894Z"
    },
    {
      "type": "GEOGRAPHY",
      "text": "In fiscal 2025/26, Sectra reported net sales of SEK 3,541.7 million. By geographic market, sales were SEK 1,086.4 million in the United States (30.7%), SEK 684.2 million in Sweden (19.3%), SEK 580.1 million in the United Kingdom (16.4%), SEK 850.5 million in the rest of Europe (24.0%), and SEK 340.5 million in the rest of the world (9.6%). Percentages are calculated from the reported amounts and total. [T14245193]\n\nSectra reported more than 1,400 employees in 17 countries and customers in over 60 countries in 2025/26; the cited report material does not give employee counts by country. [https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf] Its contact page lists locations across Australia, Benelux, Canada, Denmark, France, Germany, Norway, Portugal, Switzerland, the UK and Ireland, the USA, and Sweden, including Linköping, Stockholm, and Örebro in Sweden. [https://career.sectra.com/contact/] The 2025/26 year-end report also notes an office opened in Denver, Colorado, to strengthen customer presence in the western United States. [P124247074]\n[T14245193][T14245193][T14245193][T14245193][T14245193][T14245193][https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf][https://career.sectra.com/contact/][P124247074][https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf][https://career.sectra.com/contact/]",
      "updatedAt": "2026-10-04T15:10:42.309894Z"
    },
    {
      "type": "SEGMENTS",
      "text": "For fiscal 2025/26 (May 1, 2025–April 30, 2026), Sectra reported three operating areas. Imaging IT Solutions focuses on medical IT systems and services for managing medical images and related patient information; sales were SEK 3,057.4 million. Secure Communications provides encryption and secure communications for defense, public authorities, and other critical functions; sales were SEK 453.0 million. Business Innovation includes Orthopaedics, Genomics IT, Medical Education, research and medical AI, and patent-portfolio management; sales were SEK 107.2 million. [T14245175][T14245176][T14245177][https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf][https://investor.sectra.com/this-is-sectra/our-business-operations/imaging-it-solutions/][https://investor.sectra.com/this-is-sectra/our-business-operations/secure-communications/][https://investor.sectra.com/this-is-sectra/our-business-operations/business-innovation/]\n\nSectra’s rounded sales mix for these operating areas was approximately 84% Imaging IT Solutions, 13% Secure Communications, and 3% Business Innovation. The reported area sales total SEK 3,617.6 million, which exceeds consolidated Group net sales of SEK 3,541.7 million; consequently, these percentages describe the operating-area mix and should not be treated as a reconciled allocation of consolidated net sales. The report also presents Other Operations separately. [T14245175][T14245176][T14245177][T14245203][https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf]\n[T14245175][T14245176][T14245177][T14245203][https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf][https://investor.sectra.com/this-is-sectra/our-business-operations/imaging-it-solutions/][https://investor.sectra.com/this-is-sectra/our-business-operations/secure-communications/][https://investor.sectra.com/this-is-sectra/our-business-operations/business-innovation/]",
      "updatedAt": "2026-10-04T15:10:42.309894Z"
    },
    {
      "type": "HISTORY",
      "text": "Sectra was founded in Linköping in 1978 by Professor Ingemar Ingemarsson and postgraduate students Viiveke Fåk, Rolf Blom and Robert Forchheimer to develop security solutions for banks. The company received a defense cryptography order in 1987 and entered digital radiology image management in 1989; in 1993, its technology was used in Sweden’s first film-free radiology department, in Mjölby. [https://investor.sectra.com/this-is-sectra/sectras-history/]\n\nSectra established its first subsidiary outside Sweden, in Norway, in 1995, and went public on the Stockholm Stock Exchange in 1999. Around that time, it acquired RadiSoft AB, broadening its imaging software business to include radiology information systems and mammography-screening administration; in 2000, it introduced digital mammography with Mamea Imaging AB. [https://investor.sectra.com/this-is-sectra/sectras-history/][https://investor.sectra.com/wp-content/uploads/sites/2/2019/04/sectra-annual-report-9899eng.pdf][https://investor.sectra.com/sectra_annual_report_2000eng/][https://investor.sectra.com/sectra_annual_report_0102_eng/]\n\nIn 2012, Torbjörn Kronander became President and CEO, succeeding Jan-Olof Brüer, who had led the company as CEO since 1985. [https://investor.sectra.com/governance/executive-management/][https://investor.sectra.com/governance/board-of-directors/]\n[https://investor.sectra.com/this-is-sectra/sectras-history/][https://investor.sectra.com/wp-content/uploads/sites/2/2019/04/sectra-annual-report-9899eng.pdf][https://investor.sectra.com/sectra_annual_report_2000eng/][https://investor.sectra.com/sectra_annual_report_0102_eng/][https://investor.sectra.com/governance/executive-management/][https://investor.sectra.com/governance/board-of-directors/][https://investor.sectra.com/this-is-sectra/sectras-history/][https://investor.sectra.com/wp-content/uploads/sites/2/2019/04/sectra-annual-report-9899eng.pdf][https://investor.sectra.com/sectra_annual_report_2000eng/][https://investor.sectra.com/sectra_annual_report_0102_eng/][https://investor.sectra.com/governance/executive-management/][https://investor.sectra.com/governance/board-of-directors/]",
      "updatedAt": "2026-10-04T15:10:42.309894Z"
    }
  ],
  "sources": [
    {
      "id": "https://investor.sectra.com/this-is-sectra/our-business-operations/",
      "href": "https://investor.sectra.com/this-is-sectra/our-business-operations/",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://investor.sectra.com/this-is-sectra/our-business-operations/imaging-it-solutions/",
      "href": "https://investor.sectra.com/this-is-sectra/our-business-operations/imaging-it-solutions/",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://investor.sectra.com/this-is-sectra/our-business-operations/secure-communications/",
      "href": "https://investor.sectra.com/this-is-sectra/our-business-operations/secure-communications/",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://investor.sectra.com/this-is-sectra/our-business-operations/business-innovation/",
      "href": "https://investor.sectra.com/this-is-sectra/our-business-operations/business-innovation/",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://sectra.com/",
      "href": "https://sectra.com/",
      "label": "sectra.com"
    },
    {
      "id": "https://investor.sectra.com/this-is-sectra/sectras-history/",
      "href": "https://investor.sectra.com/this-is-sectra/sectras-history/",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf",
      "href": "https://investor.sectra.com/wp-content/uploads/sites/2/2026/07/sectra-ar2526-eng-final-web.pdf",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://medical.sectra.com/product/sectra-ids7/",
      "href": "https://medical.sectra.com/product/sectra-ids7/",
      "label": "medical.sectra.com"
    },
    {
      "id": "https://medical.sectra.com/product/sectra-vna/",
      "href": "https://medical.sectra.com/product/sectra-vna/",
      "label": "medical.sectra.com"
    },
    {
      "id": "https://medical.sectra.com/product/sectra-one-cloud/",
      "href": "https://medical.sectra.com/product/sectra-one-cloud/",
      "label": "medical.sectra.com"
    },
    {
      "id": "https://medical.sectra.com/product/sectra-digital-pathology-solution/",
      "href": "https://medical.sectra.com/product/sectra-digital-pathology-solution/",
      "label": "medical.sectra.com"
    },
    {
      "id": "https://medical.sectra.com/product/sectra-breast-imaging-pacs-ris/",
      "href": "https://medical.sectra.com/product/sectra-breast-imaging-pacs-ris/",
      "label": "medical.sectra.com"
    },
    {
      "id": "https://medical.sectra.com/product/sectra-cardiology-solution/",
      "href": "https://medical.sectra.com/product/sectra-cardiology-solution/",
      "label": "medical.sectra.com"
    },
    {
      "id": "https://medical.sectra.com/product/sectra-2d-planning-system/",
      "href": "https://medical.sectra.com/product/sectra-2d-planning-system/",
      "label": "medical.sectra.com"
    },
    {
      "id": "https://communications.sectra.com/product/mobile-communication-up-to-secret/",
      "href": "https://communications.sectra.com/product/mobile-communication-up-to-secret/",
      "label": "communications.sectra.com"
    },
    {
      "id": "https://communications.sectra.com/product/sectra-managed-detection-and-response/",
      "href": "https://communications.sectra.com/product/sectra-managed-detection-and-response/",
      "label": "communications.sectra.com"
    },
    {
      "id": "P124247344",
      "href": "https://app.finbar.com/go?id=P124247344",
      "label": "SECTRA 'B' — Partial financial report (2026 Y), p20",
      "documentId": "D-24e9a917fe304f4c82a0f27013cfed5c",
      "page": 20
    },
    {
      "id": "T14245175",
      "href": "https://app.finbar.com/go?id=T14245175",
      "label": "SECTRA 'B' — Partial financial report (2026 Y), p10",
      "documentId": "D-24e9a917fe304f4c82a0f27013cfed5c",
      "page": 10
    },
    {
      "id": "T14245176",
      "href": "https://app.finbar.com/go?id=T14245176",
      "label": "SECTRA 'B' — Partial financial report (2026 Y), p11",
      "documentId": "D-24e9a917fe304f4c82a0f27013cfed5c",
      "page": 11
    },
    {
      "id": "T14245177",
      "href": "https://app.finbar.com/go?id=T14245177",
      "label": "SECTRA 'B' — Partial financial report (2026 Y), p12",
      "documentId": "D-24e9a917fe304f4c82a0f27013cfed5c",
      "page": 12
    },
    {
      "id": "T14245193",
      "href": "https://app.finbar.com/go?id=T14245193",
      "label": "SECTRA 'B' — Partial financial report (2026 Y), p21",
      "documentId": "D-24e9a917fe304f4c82a0f27013cfed5c",
      "page": 21
    },
    {
      "id": "https://career.sectra.com/contact/",
      "href": "https://career.sectra.com/contact/",
      "label": "career.sectra.com"
    },
    {
      "id": "P124247074",
      "href": "https://app.finbar.com/go?id=P124247074",
      "label": "SECTRA 'B' — Partial financial report (2026 Y), p4",
      "documentId": "D-24e9a917fe304f4c82a0f27013cfed5c",
      "page": 4
    },
    {
      "id": "T14245203",
      "href": "https://app.finbar.com/go?id=T14245203",
      "label": "SECTRA 'B' — Partial financial report (2026 Y), p24",
      "documentId": "D-24e9a917fe304f4c82a0f27013cfed5c",
      "page": 24
    },
    {
      "id": "https://investor.sectra.com/wp-content/uploads/sites/2/2019/04/sectra-annual-report-9899eng.pdf",
      "href": "https://investor.sectra.com/wp-content/uploads/sites/2/2019/04/sectra-annual-report-9899eng.pdf",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://investor.sectra.com/sectra_annual_report_2000eng/",
      "href": "https://investor.sectra.com/sectra_annual_report_2000eng/",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://investor.sectra.com/sectra_annual_report_0102_eng/",
      "href": "https://investor.sectra.com/sectra_annual_report_0102_eng/",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://investor.sectra.com/governance/executive-management/",
      "href": "https://investor.sectra.com/governance/executive-management/",
      "label": "investor.sectra.com"
    },
    {
      "id": "https://investor.sectra.com/governance/board-of-directors/",
      "href": "https://investor.sectra.com/governance/board-of-directors/",
      "label": "investor.sectra.com"
    }
  ]
}